ARX:ASX
Aroa Biosurgery Ltd
0,48 A$
arrow_downward
-1,02%(-0,0050) 1D
20 қар., 16:10:08 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 A$
High
0,50 A$
Low
0,48 A$
Mkt. cap
167,76 млн
Avg. vol.
259,42 м.
Volume
192,34 м.
P/E ratio
46,19
52-wk high
0,78 A$
52-wk low
0,46 A$
EPS
0,01 A$
Shares outstanding
345,90 млн
No. of employees
261
Open
0,50 A$
High
0,50 A$
Low
0,48 A$
Mkt. cap
167,76 млн
Avg. vol.
259,42 м.
Volume
192,34 м.
P/E ratio
46,19
52-wk high
0,78 A$
52-wk low
0,46 A$
EPS
0,01 A$
Shares outstanding
345,90 млн
No. of employees
261
News stories
From web sources and news partners
AP News
·
1 күн бұрын
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Beinsure
·
14 сағат бұрын
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Yahoo Finance
·
9 сағат бұрын
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
WSJ
·
1 күн бұрын
Dow, S&P 500 Poised to Close at a Correction
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd